Introducing Kleanthi Diagnostics

Our Approach

Kleanthi Diagnostics is a biotechnology company involved in developing diagnostic tools for oxidation-related diseases. The company was co-founded by Sotirios Tsimikas, MD and Joseph L. Witztum, MD, both of whom are renowned in the field of cardiovascular research. Kleanthi Diagnostics focuses on creating and utilizing biomarkers related to oxidized lipoproteins, which play a significant role in conditions like like atherosclerosis, aortic stenosis, neurodegenerative diseases, and age-related inflammatory conditions.